510(k) Report

510(k) · Cleared

Cleared

Xpert GI Panel

K251721510(k) TraditionalCleared Jan 16, 2026226-day reviewClass II21 CFR 866.3990

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cepheid · PCH Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System

Cleared on Jan 16, 2026 as substantially equivalent to K140407 (Biofire Diagnostics, 2014) after a 226-day review. Its family tree reaches back 2 generations to 2013.

Decided
Jan 16, 2026
Review
226 days
Class
Class II
Product code
PCH
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN130003 (2013). No later device cites it as a predicate yet.

  1. Root · 2 generations backDEN130003 Xtag Gastrointestinal Pathogen Panel (GPP) Xtag Data Analysis…Luminex Molecular Diagnostics, Inc. · 2013
  2. 1 generation backK140407 Filmarray Gastrointestinal (GI) PanelBiofire Diagnostics · 2014 · Recalled
  3. This deviceK251721 Xpert GI PanelCepheid · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN130003Xtag Gastrointestinal Pathogen Panel (GPP) Xtag Data Analysis Software for GPP…Luminex Molecular Diagnostics, Inc.2013—
−1K140407Filmarray Gastrointestinal (GI) PanelBiofire Diagnostics20148
0 (this device)K251721Xpert GI PanelCepheid2026—
FIG. 1 — Lineage of K251721, 2013–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PCH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PCH device

  1. #1 K220062 QIAstat-Dx Gastrointestinal Panel 2score 16.7 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K140407Filmarray Gastrointestinal (GI) Panel
Summary page 8
…) Classification Advisory Panel: Microbiology Prescription Use: Yes Predicate Device Assay: FilmArray Gastrointestinal (GI) Panel (K140407) 510(k) Summary Page 3 of 34 Xpert® GI P…
Biofire Diagnostics20148

Also cleared against K140407: 7 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 11.7 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • 7 other devices also cite its predicate K140407.

How does its category compare?

All PCH devices

PCH Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · PCH

7in 2025

2013: 32014: 62015: 22016: 22017: 12018: 42019: 42022: 22023: 12024: 32025: 72026 (partial year): 3
2007high 7 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PCH

89in 2025

2014: 120 days median2018: 105 days median2019: 191 days median2024: 271 days median2025: 89 days median2026 (partial year): 176 days median
2007high 271 (2024) · low 89 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PCH

5in 2025

2023: 12025: 5
2007high 5 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PCH

40in 2025

2014: 12019: 42021: 262022: 472023: 622024: 452025: 40
2007high 62 (2023) · low 0 (2007)2025

MAUDE reports naming product code PCH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20133—00
2014612001
20152—00
20162—00
20171—00
2018410500
2019419104
20200—00
20210—026
20222—047
20231—162
20243271045
2025789540
202631760—

What is it indicated for?

The Xpert GI Panel, performed on the GeneXpert® Instrument Systems, is a qualitative multiplexed in vitro diagnostic test that is capable of the simultaneous detection and identification of DNA and RNA from multiple bacteria, parasites and/or virus directly from stool samples in Cary Blair transport media obtained from individuals with signs and symptoms of gastrointestinal infection. The test utilizes automated, qualitative real time polymerase chain…

Read the full statement (245 words)

The Xpert GI Panel, performed on the GeneXpert® Instrument Systems, is a qualitative multiplexed in vitro diagnostic

test that is capable of the simultaneous detection and identification of DNA and RNA from multiple bacteria, parasites

and/or virus directly from stool samples in Cary Blair transport media obtained from individuals with signs and symptoms

of gastrointestinal infection. The test utilizes automated, qualitative real time polymerase chain reaction (PCR). The

following bacteria (including several diarrheagenic E. coli/Shigella pathotypes), parasites, and virus are identified using

the Xpert GI Panel:

Pathogens Detected:

Bacteria: Campylobacter (C. jejuni/C. coli), Shiga toxin-producing Escherichia coli (STEC) stx1/stx2, Salmonella,

Shigella/Enteroinvasive Escherichia coli, Yersinia enterocolitica, Vibrio parahaemolyticus, Vibrio cholerae

Parasites: Giardia (also known as G. intestinalis, G. duodenalis & G. lamblia), Cryptosporidium

Virus: Norovirus GI/GII

Pathogens Reported:

Bacteria: Campylobacter, STEC stx1, STEC stx2, Salmonella, Shigella EIEC, Yersinia, V. parahaemolyticus, V. cholerae

Parasites: Giardia, Cryptosporidium

Virus: Norovirus

Results are meant to be used in conjunction with other clinical, laboratory and epidemiological data and should not be

used as the sole basis for diagnosis, treatment or other patient management decisions. Positive results do not rule out co-

infection with pathogens not included in the Xpert GI Panel. The pathogen detected may not be the definite cause of the

disease. Negative results in the setting of clinical illness compatible with gastroenteritis may be due to infection by

pathogens that are not detected by this test or non-infectious causes such as ulcerative colitis, irritable bowel syndrome, or

Crohn’s disease.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K251721: Xpert GI Panel.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251721

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026